Kodiak Sciences to Present at Upcoming Investor Conferences

Rhea-AI Summary

Kodiak Sciences (Nasdaq: KOD) announced that CEO Victor Perlroth, M.D. will present at two upcoming investor conferences: the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:30pm GMT (8:30am PST) and the 8th Annual Evercore Healthcare Conference in Coral Gables on Wednesday, December 3, 2025 at 3:00pm EST (12:00pm PST).

The Jefferies appearance will be a presentation; the Evercore session will be a fireside chat. A live webcast of both events will be available in the Events and Presentations section of Kodiak's investor website at http://ir.kodiak.com/ and will be available for replay for a limited time.

PALO ALTO, Calif., Nov. 12, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that Victor Perlroth, M.D., Chief Executive Officer, will present at the following upcoming investor conferences:

• Jefferies Global Healthcare Conference in London, UK 
  • Date: Monday, November 17, 2025
  • Time: 4:30pm GMT (8:30am PST)
  • Format: Presentation
    
    
• 8^th Annual Evercore Healthcare Conference in Coral Gables, Florida
• • Date: Wednesday, December 3, 2025
  • Time: 3:00pm EST (12pm PST)
  • Format: Fireside chat
    
    

A live webcast of both presentations will be available on the "Events and Presentations" section of Kodiak's website at http://ir.kodiak.com/ and will remain available for replay for a limited time following the event.

About Kodiak Sciences Inc.

Kodiak Sciences (Nasdaq: KOD) is a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics. We are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Our ABC^® Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies and has been at the core of Kodiak's discovery engine. We are developing a portfolio of three late-stage clinical programs. Tarcocimab and KSI-501 are being explored in two BLA-facing Phase 3 studies in the retinal vascular diseases, targeting the $15 billion anti-VEGF marketplace. KSI-101 is a bispecific protein being explored in two Phase 3 studies in Macular Edema Secondary to Inflammation (MESI).

For more information, please visit www.kodiak.com.

Kodiak^®, Kodiak Sciences^®, ABC^®, ABC Platform^®, ABCD^™ and the Kodiak logo are registered trademarks or trademarks of Kodiak Sciences Inc. in various global jurisdictions.

View original content:https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-upcoming-investor-conferences-302613755.html

SOURCE Kodiak Sciences Inc.

FAQ

When will Kodiak Sciences (KOD) present at the Jefferies Global Healthcare Conference?

Kodiak Sciences will present on Monday, November 17, 2025 at 4:30pm GMT (8:30am PST).

What is the date and format of Kodiak Sciences (KOD) presentation at the Evercore Healthcare Conference?

The Evercore session is on Wednesday, December 3, 2025 at 3:00pm EST (12:00pm PST) and will be a fireside chat.

How can investors watch Kodiak Sciences (KOD) presentations live or on replay?

A live webcast will be available on Kodiak's Events and Presentations page at http://ir.kodiak.com/ and will remain available for replay for a limited time.

Who will represent Kodiak Sciences (KOD) at the November–December 2025 investor conferences?

Victor Perlroth, M.D., Chief Executive Officer, will present at both conferences.

What time is the Jefferies presentation for Kodiak Sciences (KOD) in Pacific Time?

The Jefferies presentation is scheduled for 8:30am PST on November 17, 2025.